Introduction: The pandemic has created an opportunity to explore different testing settings. However, transitioning to remote testing raises concerns about cheating. The possibility of cheating raises concern about the integrity of test psychometrics. In 2020, the orthopaedic in-training examination (OITE) was offered using two administration models, with programs having the option to provide physically distanced, in-person, proctored testing or remote testing and online proctoring. We aimed to determine whether scores were higher when the OITE was administered and proctored remotely.
Methods: Residents of allopathic programs from the 2020 administration of the OITE were included. The American Academy of Orthopaedic Surgeons database of examinees and deidentified aggregate scores were compared. The primary outcome variable was the number of items answered correctly. Of 275 questions and after psychometric analysis, eight questions were excluded, leaving 267 questions as the denominator for percent correct. The mean number of items answered correctly was compared between the group with in-person proctoring and the group with virtual, digital proctoring using the two-sample Student t-test.
Results: A total of 4405 examinees consisted of two cohorts: 1834 residents (42%) took the OITE with in-person proctoring and 2571 residents (58%) completed the test in the remote testing and proctoring models. No difference in mean scores was observed between in-person proctored and remotely proctored examinees (in-person: 162.98 ± 21.11, remote: 162.22 ± 22.04, mean difference: -0.75 [95% CI, -2.04 to 0.53]; P = 0.25).
Discussion: Remote testing with virtual proctoring has become more widely used. There was no difference in scores and no evidence of enough cheating to change the "curve" of the OITE. Knowing that there was no evidence of sufficient cheating to change overall test psychometrics, programs and residents can be reassured that the OITE remains a valid educational instrument even when administered remotely.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812626 | PMC |
http://dx.doi.org/10.5435/JAAOSGlobal-D-21-00225 | DOI Listing |
BAY 2413555 is a novel selective and reversible positive allosteric modulator of the type 2 muscarinic acetylcholine (M2) receptor, aimed at enhancing parasympathetic signaling and restoring cardiac autonomic balance for the treatment of heart failure (HF). This study tested the safety, tolerability and pharmacokinetics of this novel therapeutic option. REMOTE-HF was a multicenter, double-blind, randomized, placebo-controlled, phase Ib dose-titration study with two active arms.
View Article and Find Full Text PDFCureus
November 2024
Department of Emergency Medicine, Ibn Sina Hospital, Makkah, SAU.
Emergency departments (EDs) encounter substantial challenges during peak vacation periods, including increased patient volumes, limited access to medical histories, language and cultural barriers, insurance complexities, and disruptions in continuity of care. These factors strain emergency department operations, resulting in prolonged wait times, diagnostic errors, and compromised care quality. This study reviews the literature to identify patient satisfaction indicators and common challenges and evaluate strategies to improve patient outcomes during vacation-related emergency department visits.
View Article and Find Full Text PDFValue Health
December 2024
FamilieSCN2A Foundation, E. Longmeadow, MA, USA; Decoding Developmental Epilepsies - DEE-P Connections; Washington, DC, USA; Northwestern Feinberg School of Medicine, Dept. Neurology, Chicago, IL, USA.
Objectives: For individuals living with rare neurodevelopmental disorders, especially those who are at the most severe end of the spectrum, standardized outcome measures may lack the sensitivity to capture small but meaningful changes. Personalized endpoints such as Goal Attainment Scaling (GAS) allow the assessment of treatment response across variable baseline states and disease manifestations and thus provide a highly sensitive measure of efficacy. The current study tested the feasibility of using GAS in rare SCN2A-associated developmental and epileptic encephalopathy (SCN2A-DEE).
View Article and Find Full Text PDFBurns
December 2024
Children's Health Research Centre, The University of Queensland, Faculty of Medicine, Herston, Queensland, Australia; Australian Centre for Health Services Innovation (AusHI), Centre for Healthcare Transformation, School of Public Health and Social Work, Queensland University of Technology, Kelvin Grove, Queensland, Australia.
Introduction: The Brisbane Burn Scar Impact Profile (BBSIP) and the Patient and Observer Scar Assessment Scale (POSAS) are used in burn scar assessment to quantify patient health-related quality of life (HR-QoL). These questionnaires were developed using pen-and-paper delivery methods; however, there is a push towards electronic delivery of these questionnaires in both clinical practice and research. Equivalence testing is required to ensure that validity of these paper questionnaires is maintained electronically.
View Article and Find Full Text PDFBMJ Case Rep
December 2024
Department of Psychiatry, Osaka University, Suita, Osaka, Japan.
Temporal lobe epilepsy (TLE) can cause different types of memory impairments. Here, we report a case of immediate improvement of memory impairment following antiepileptic drug (AED) treatment in a patient with TLE with amygdala enlargement (TLE-AE), who rapidly developed recurrence. The patient was a man in his 60s whose family members complained of his amnesia.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!